Somatix Readies Market Launch of First-of-its-Kind Wearable Medication Compliance Feature
Somatix is preparing the market launch of a unique wearable medication compliance feature that uses artificial intelligence and gesture detection algorithms to detect when patients take or miss their medication doses39.
The technology, implemented through Somatix’s SafeBeing platform, was successfully piloted in Portuguese hospitals and clinics in collaboration with Roche Pharmaceuticals as part of an open innovation program focused on dementia care125.
The system works by passively monitoring patient gestures via wearables to identify medication intake, hydration, falls risk, and other health indicators, supporting both remote monitoring and telehealth settings57.
Clinical pilots demonstrated that the platform could detect pills taken and missed with over 70% accuracy, with planned improvements aiming for close to 90% detection accuracy in future updates; hydration detection reached about 95% accuracy12.
This first-of-its-kind feature targets patients with early to mid-stage dementia, aiming to improve medication adherence, reduce preventable health risks, and help maintain patient independence12.
Somatix and Roche plan to expand their partnership to deploy the platform more broadly to outpatients in Europe in the near future12.
The technology is cloud-based, utilizing Amazon Web Services for scalable deployment across European clinical sites1.
Sources:
1. https://www.newswire.com/news/somatix-and-roche-launch-an-only-of-its-kind-medication-compliance-22080749
2. https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/somatix-and-roche-launch-an-only-of-its-kind-medication-compliance-cap-766727
3. https://www.harrisburgdailydigest.com